These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
522 related articles for article (PubMed ID: 28971508)
1. Current review-The rise of bacteriophage as a unique therapeutic platform in treating peri-prosthetic joint infections. Akanda ZZ; Taha M; Abdelbary H J Orthop Res; 2018 Apr; 36(4):1051-1060. PubMed ID: 28971508 [TBL] [Abstract][Full Text] [Related]
2. 2020 John Charnley Award: The antimicrobial potential of bacteriophage-derived lysin in a murine debridement, antibiotics, and implant retention model of prosthetic joint infection. Sosa BR; Niu Y; Turajane K; Staats K; Suhardi V; Carli A; Fischetti V; Bostrom M; Yang X Bone Joint J; 2020 Jul; 102-B(7_Supple_B):3-10. PubMed ID: 32600192 [TBL] [Abstract][Full Text] [Related]
3. Successful Treatment of Ramirez-Sanchez C; Gonzales F; Buckley M; Biswas B; Henry M; Deschenes MV; Horne B; Fackler J; Brownstein MJ; Schooley RT; Aslam S Viruses; 2021 Jun; 13(6):. PubMed ID: 34205687 [TBL] [Abstract][Full Text] [Related]
4. Past and Future of Phage Therapy and Phage-Derived Proteins in Patients with Bone and Joint Infection. Ferry T; Kolenda C; Briot T; Souche A; Lustig S; Josse J; Batailler C; Pirot F; Medina M; Leboucher G; Laurent F; On Behalf Of The Lyon Bji Study Group ; On Behalf Of The PHAGEinLYON Study Group Viruses; 2021 Dec; 13(12):. PubMed ID: 34960683 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of Bacteriophage Anti-Biofilm Activity for Potential Control of Orthopedic Implant-Related Infections Caused by Staphylococcus aureus. Morris J; Kelly N; Elliott L; Grant A; Wilkinson M; Hazratwala K; McEwen P Surg Infect (Larchmt); 2019 Jan; 20(1):16-24. PubMed ID: 30207891 [TBL] [Abstract][Full Text] [Related]
7. Phage Activity against Planktonic and Biofilm Staphylococcus aureus Periprosthetic Joint Infection Isolates. Totten KMC; Patel R Antimicrob Agents Chemother; 2022 Jan; 66(1):e0187921. PubMed ID: 34662191 [TBL] [Abstract][Full Text] [Related]
8. The Rationale for Using Bacteriophage to Treat and Prevent Periprosthetic Joint Infections. Van Belleghem JD; Manasherob R; Miȩdzybrodzki R; Rogóż P; Górski A; Suh GA; Bollyky PL; Amanatullah DF Front Microbiol; 2020; 11():591021. PubMed ID: 33408703 [TBL] [Abstract][Full Text] [Related]
9. Assessment of Staphylococcal Clinical Isolates from Periprosthetic Joint Infections for Potential Bacteriophage Therapy. DePalma BJ; Nandi S; Chaudhry W; Lee M; Johnson AJ; Doub JB J Bone Joint Surg Am; 2022 Apr; 104(8):693-699. PubMed ID: 35167506 [TBL] [Abstract][Full Text] [Related]
11. Biofilms in Periprosthetic Joint Infections: A Review of Diagnostic Modalities, Current Treatments, and Future Directions. Shoji MM; Chen AF J Knee Surg; 2020 Feb; 33(2):119-131. PubMed ID: 31935760 [TBL] [Abstract][Full Text] [Related]
12. The role of microbial biofilms in prosthetic joint infections. Gbejuade HO; Lovering AM; Webb JC Acta Orthop; 2015 Apr; 86(2):147-58. PubMed ID: 25238433 [TBL] [Abstract][Full Text] [Related]
13. Mouse model of Gram-negative prosthetic joint infection reveals therapeutic targets. Thompson JM; Miller RJ; Ashbaugh AG; Dillen CA; Pickett JE; Wang Y; Ortines RV; Sterling RS; Francis KP; Bernthal NM; Cohen TS; Tkaczyk C; Yu L; Stover CK; DiGiandomenico A; Sellman BR; Thorek DL; Miller LS JCI Insight; 2018 Sep; 3(17):. PubMed ID: 30185667 [TBL] [Abstract][Full Text] [Related]
14. What Is the Role of Diagnostic and Therapeutic Sonication in Periprosthetic Joint Infections? Hameister R; Lim CT; Lohmann CH; Wang W; Singh G J Arthroplasty; 2018 Aug; 33(8):2575-2581. PubMed ID: 29599035 [TBL] [Abstract][Full Text] [Related]
15. Bacteriophage therapy for bone and joint infections. Gibb BP; Hadjiargyrou M Bone Joint J; 2021 Feb; 103-B(2):234-244. PubMed ID: 33517726 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of bacteriophage as an adjunct therapy for treatment of peri-prosthetic joint infection caused by Staphylococcus aureus. Morris JL; Letson HL; Elliott L; Grant AL; Wilkinson M; Hazratwala K; McEwen P PLoS One; 2019; 14(12):e0226574. PubMed ID: 31877146 [TBL] [Abstract][Full Text] [Related]
18. In vivo analysis of a first-in-class tri-alkyl norspermidine-biaryl antibiotic in an active release coating to reduce the risk of implant-related infection. Williams DL; Epperson RT; Ashton NN; Taylor NB; Kawaguchi B; Olsen RE; Haussener TJ; Sebahar PR; Allyn G; Looper RE Acta Biomater; 2019 Jul; 93():36-49. PubMed ID: 30710710 [TBL] [Abstract][Full Text] [Related]
19. Early prosthetic hip joint infection treated with debridement, prosthesis retention and biofilm-active antibiotics: functional outcomes, quality of life and complications. Aboltins C; Dowsey MM; Peel T; Lim WK; Parikh S; Stanley P; Choong PF Intern Med J; 2013 Jul; 43(7):810-5. PubMed ID: 23656615 [TBL] [Abstract][Full Text] [Related]
20. Human prosthetic joint infections are associated with myeloid-derived suppressor cells (MDSCs): Implications for infection persistence. Heim CE; Vidlak D; Odvody J; Hartman CW; Garvin KL; Kielian T J Orthop Res; 2018 Jun; 36(6):1605-1613. PubMed ID: 29139571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]